Document is current
Any future updates will be listed below
-
Authors
Shah, Hiral Anil https://orcid.org/0000-0003-0204-451X
Jutlla, Ginita https://orcid.org/0000-0001-6065-8574
Herrera-Restrepo, Oscar https://orcid.org/0000-0001-8193-999X
Graham, Jonathan https://orcid.org/0000-0002-3227-5928
Hicks, Katherine A. https://orcid.org/0000-0002-1058-3401
Carrico, Justin https://orcid.org/0000-0002-4659-9309
Grace, Mei https://orcid.org/0009-0008-3862-8203
Clements, Diana E. https://orcid.org/0000-0002-2410-8951
Burman, Cindy https://orcid.org/0009-0000-2860-1500
Sohn, Woo-Yun https://orcid.org/0000-0002-4034-4735
Kuylen, Elise https://orcid.org/0000-0002-3528-5507
Begum, Shahina https://orcid.org/0000-0002-3521-8865
Kocaata, Zeki https://orcid.org/0000-0002-5231-3389
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals
- License Information
-
More Information
Article History
Accepted: 22 September 2024
First Online: 25 November 2024
Declarations
:
: This study was sponsored by GSK. Support for third-party writing assistance for this article was funded by GSK in accordance with Good Publication Practice (GPP 2022) guidelines ().
: HAS, OH-R, JC, DC, W-YS, EK, ZK: employee and shareholder of GSK; GJ: employee of and received consulting fees from GSK; JG, KAH, MG: employee of RTI Health Solutions, which received payment for this study from GSK; CB: employee and shareholder of GSK, shareholder of Pfizer; SB: employee of GSK.
: The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Data obtained utilizing this model were presented at the European Society for Paediatric Infectious Diseases (ESPID) 2024 annual meeting.
: Substantial contributions to study conception and design: HAS, GJ, OH-R, ZK; substantial contributions to analysis or interpretation of the data: HAS, GJ, OH-R, JG, KAH, JC, MG, DC, CB, W-YS, EK, SB, ZK; drafting the article or revising it critically for important intellectual content: HAS, GJ, OH-R, JG, KAH, JC, MG, DC, CB, W-YS, EK, SB, ZK; final approval of the version of the article to be published: HAS, GJ, OH-R, JG, KAH, JC, MG, DC, CB, W-YS, EK, SB, ZK.
